ATXS
Astria Therapeutics·NASDAQ
--
--(--)
--
--(--)
ATXS Filings
Filing Date
Form Description
Form Type
2025-12-23
Form 425 - Prospectuses and communications, business combinations
Key Events
2025-12-23 · Key Events
Form 425 - Prospectuses and communications, business combinations
2025-12-23
Form 8-K - Current report
Key Events
2025-12-23 · Key Events
Form 8-K - Current report
2025-12-18
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-18 ·
Form DEFM14A - Definitive proxy statement relating to merger or acquisition
2025-12-10
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-10 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-03
Form 425 - Prospectuses and communications, business combinations
Key Events
2025-12-03 · Key Events
Form 425 - Prospectuses and communications, business combinations
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
